Corvus Pharmaceuticals, Inc.·4

Dec 14, 4:05 PM ET

Verner Erik J. 4

4 · Corvus Pharmaceuticals, Inc. · Filed Dec 14, 2018

Insider Transaction Report

Form 4
Period: 2018-12-12
Verner Erik J.
V.P., Chemistry Research
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-12-1250,00050,000 total
    Exercise: $5.94Exp: 2028-12-12Common Stock (50,000 underlying)
Holdings
  • Common Stock, $0.0001 par value

    63,773
Footnotes (2)
  • [F1]A portion of these shares is subject to a right of repurchase held by the Issuer.
  • [F2]The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION